Furthermore, we performed a sensitive enzyme-linked immunosorbent assay (ELISA) to determine the concentration of IAPP in the CSF from control subjects and AD patients (Table S2), and found that the concentrations of IAPP in the CSF of AD patients were much higher than that in the healthy controls (Fig. 1d). This evidence concerns the gene IAPP and Alzheimer disease.